GoodRx Holdings, Inc. files for IPO.

IPO of the leading telemedicine platform in the US GoodRx Holdings, Inc. (GDRX) will take place on September 22. 

GoodRx's patented platform enables to collect daily over 150 billion prescription price data from sources covering the healthcare industry.

Initially GoodRx was founded just as a drug price comparison tool, but now the platform provides access to health care providers consultations through telemedicine, as well as many other additional medical services, including  medical insurance.  

The GoodRx platform enables consumers to reduce their healthcare costs, and to speed up treatment and improve its results.

The IPO bookrunners are Morgan Stanley, Goldman Sachs, JP Morgan, Barclays, BofA Securities, Citigroup, Credit Suisse, RBC Capital Markets, UBS Investment Bank, Cowen, Deutsche Bank Securities and Evercore ISI.